Market Closed - OTC Markets 21:44:37 08/07/2025 HKT 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for DiaSys Corporation -.--% -

Valuation: DiaSys Corporation

Market Cap 51.44K 45.05K 41.5K 38.52K 73.15K 4.91M 74.13K 497K 193K 2.41M 193K 189K 8.35M P/E 2006
-3.78x
P/E 2007 -3x
Enterprise Value 646K 566K 521K 484K 918K 61.61M 931K 6.24M 2.43M 30.24M 2.43M 2.37M 105M EV / Sales 2006
2.7x
EV / Sales 2007 2.04x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0
10 years 0
Extreme 0
0
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
-1.12%+2.21%+20.56%+0.05% 192B
+1.60%+6.62%-20.50%+31.10% 153B
-2.18%+0.44%-4.71%-17.40% 137B
-1.20%+2.58%-57.25%-15.66% 66.29B
+0.86%+4.39%+23.95%+5.22% 54.8B
+1.16%+3.19%-24.27%-28.82% 44.44B
-0.11%+2.72%+8.19%+42.98% 37.2B
-0.07%-1.68%+7.60%+10.28% 36.89B
+4.18%+10.06%-15.01%+1.58% 31.5B
Average +0.59%+2.71%-6.83%+3.26% 75.38B
Weighted average by Cap. +0.02%+3.29%-4.36%+3.17%

Financials

2006 2007
Net sales 1.69M 1.48M 1.36M 1.26M 2.4M 161M 2.43M 16.3M 6.34M 79.04M 6.34M 6.2M 274M 1.68M 1.47M 1.35M 1.26M 2.39M 160M 2.42M 16.2M 6.31M 78.57M 6.3M 6.16M 272M
Net income -1.05M -918K -845K -785K -1.49M -99.95M -1.51M -10.12M -3.94M -49.06M -3.93M -3.85M -170M -785K -688K -633K -588K -1.12M -74.9M -1.13M -7.58M -2.95M -36.77M -2.95M -2.88M -127M
Net Debt 302K 264K 244K 226K 429K 28.81M 435K 2.92M 1.13M 14.14M 1.13M 1.11M 49.02M 594K 521K 479K 445K 845K 56.7M 857K 5.74M 2.23M 27.83M 2.23M 2.18M 96.49M
Logo DiaSys Corporation
DiaSys Corporation (DiaSys) designs, develops, manufactures and distributes workstation-instruments, consumables, reagents and specialized test kits to hospital, clinical and private physician laboratories globally. The Company’s workstation instruments standardize laboratory analysis of urine sediment, fecal concentrates, cerebral spinal fluid (CSF), fine needle aspirations (FNA) and other cell suspensions. The Company’s wholly owned subsidiary, DiaSys Europe Limited markets the Company’s urinalysis and parasitology workstations, the full DiaSys line of rapid test kits, consumables, immunology, oncology and virology products and manufactures reagents. The two product categories of the Company are workstation-systems, and disposable consumables, diagnostic test products and kits. DiaSys sells its products in North America both directly and through strategic distribution relationships with Cardinal Heath and Fisher Healthcare.
Employees
10
  1. Stock Market
  2. Stocks
  3. DYXC Stock